Danny Silver, MD
Emergency Medicine · Fort Smith, ARNPI 1972582260
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,329 of the $7,472 with a category attached, or 71.3%. 39 manufacturers reported payments, led by Medtronic at 41.5% of the total. Reporting peaked in 2023 at $2,256 and has fallen 54.6% since, to $1,025 in 2025. Among emergency medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 275 payments — averaging $27.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$992
- Biohaven Pharmaceuticals, Inc.$429
- Collegium Pharmaceutical, Inc.$403
- AbbVie$264
- Paratek Pharmaceuticals, Inc.$223
- plus $2K from 33 others
What the payments were for
- Travel & lodging$2,10828%
- Food & beverage$5,32971%
- Education$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,582
- SYNCHROMED$824
- NURTEC ODT$299
How this compares
$7,472 in reported general payments places this provider in the 95th percentile of 388 emergency medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 178 | $119,071 |
| Buprenorphine | 319 | $99,461 |
| BelbucaBuprenorphine Hcl | 132 | $98,526 |
| RelistorMethylnaltrexone Bromide | 40 | $96,105 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 3,292 | $93,719 |
| IngrezzaValbenazine Tosylate | 25 | $92,719 |
| MovantikNaloxegol Oxalate | 196 | $85,564 |
| CopaxoneGlatiramer Acetate | 11 | $82,676 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 2,826 | $77,778 |
| EliquisApixaban | 192 | $55,263 |
| GemtesaVibegron | 207 | $50,360 |
| JardianceEmpagliflozin | 110 | $33,050 |
| Xtampza ErOxycodone Myristate | 128 | $32,273 |
| Nurtec OdtRimegepant Sulfate | 20 | $29,483 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 67 | $21,000 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta | $403 | $138,088274 claims |
| AbbVieLinzess, Vraylar | $264 | $136,209200 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $35 | $110,477791 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor, Trulance | $992 | $107,31761 claims |
| PfizerEliquis, Nurtec Odt, Abrysvo | $158 | $105,746279 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $40 | $92,71925 claims |
| Redhill Biopharma Inc.Movantik | $44 | $85,564196 claims |
| Teva Pharmaceuticals USA, Inc.Copaxone | $145 | $82,67611 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $15 | $50,360207 claims |
| Johnson & JohnsonXarelto | $18 | $14,27754 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 388 emergency medicine providers in Arkansas.
Other emergency medicine in Fort Smith
- Emily WilliamsFort Smith$1K
- Wallace LockFort Smith$782
- Aaron LawrenceFort Smith$687
- Michelle HoranFort Smith$623
- Aaron BullFort Smith$582
- James RussellFort Smith$507
- Ryan SullivanFort Smith$441
- Eric SullivanFort Smith$434
- Balasasikumar SundaramFort Smith$425
- Andrew StarnesFort Smith$249
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.